Summary of Significant Accounting Policies (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Jun. 29, 2024	Jul. 01, 2023	Dec. 30, 2023	Dec. 31, 2022
Summary of Significant Accounting Policies [Line Items]
Financing Receivable, Sale	$ 158,200	$ 130,600	$ 295,600	$ 292,000
Financing Receivable, Significant Sales, Transaction Fees	2,300	1,700	4,500	3,700
Basic:
Net income	$ 78,866	$ 252,383	$ 160,023	$ 438,184
Shares (in shares)	159,815,000	159,810,000	159,813,000	159,978,000
Per Share (in usd per share)	$ 0.49	$ 1.58	$ 1.00	$ 2.74
Effect of dilutive securities: [Abstract]
Add: Option shares in the money and dilutive effect of non-vested stock (in shares)	2,881,000	3,308,000	2,968,000	3,363,000
Less: Pro forma treasury shares (in shares)	(991,000)	(748,000)	(976,000)	(748,000)
Diluted:
Net Income	$ 78,866	$ 252,383	$ 160,023	$ 438,184
Shares (in shares)	161,705,000	162,370,000	161,805,000	162,593,000
Per Share (in usd per share)	$ 0.49	$ 1.55	$ 0.99	$ 2.69
Antidilutive Securities [Abstract]
Cash and cash equivalents	$ 121,587		$ 121,587		$ 126,502
Restricted cash	26,290		26,290		292
Restricted cash included in other long-term assets	117,715		117,715		137,656
Total cash, cash equivalents and restricted cash shown in the statement of cash flows	$ 265,592	$ 244,119	265,592	$ 244,119	264,450	$ 150,168
Revision of Prior Period, Error Correction, Adjustment
Antidilutive Securities [Abstract]
Net income period adjustments			$ 17,900
Revision of Prior Period, Error Correction, Adjustment | Overstatement
Antidilutive Securities [Abstract]
Inventory adjustments					$ 25,100
Stock Options
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	0	0	0	0
Non Vested Stock
Antidilutive Securities [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	763,104	478,289	718,563	450,248